[go: up one dir, main page]

AU2001254825A1 - Butenoic acids derivatives and their use in the treatment of rhinitis - Google Patents

Butenoic acids derivatives and their use in the treatment of rhinitis

Info

Publication number
AU2001254825A1
AU2001254825A1 AU2001254825A AU5482501A AU2001254825A1 AU 2001254825 A1 AU2001254825 A1 AU 2001254825A1 AU 2001254825 A AU2001254825 A AU 2001254825A AU 5482501 A AU5482501 A AU 5482501A AU 2001254825 A1 AU2001254825 A1 AU 2001254825A1
Authority
AU
Australia
Prior art keywords
rhinitis
treatment
acids derivatives
butenoic acids
butenoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001254825A
Inventor
Marc Gerspacher
Kenichiro Hoshiko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001254825A1 publication Critical patent/AU2001254825A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001254825A 2000-05-05 2001-05-03 Butenoic acids derivatives and their use in the treatment of rhinitis Abandoned AU2001254825A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0010958 2000-05-05
GBGB0010958.7A GB0010958D0 (en) 2000-05-05 2000-05-05 Organic compounds
PCT/EP2001/005007 WO2001085696A1 (en) 2000-05-05 2001-05-03 Butenoic acids derivatives and their use in the treatment of rhinitis

Publications (1)

Publication Number Publication Date
AU2001254825A1 true AU2001254825A1 (en) 2001-11-20

Family

ID=9891095

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001254825A Abandoned AU2001254825A1 (en) 2000-05-05 2001-05-03 Butenoic acids derivatives and their use in the treatment of rhinitis

Country Status (3)

Country Link
AU (1) AU2001254825A1 (en)
GB (1) GB0010958D0 (en)
WO (1) WO2001085696A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) 2002-02-08 2002-03-27 Novartis Ag Organic compounds
JO2630B1 (en) 2006-04-13 2012-06-17 نوفارتيس ايه جي Organic Compounds
JP5411140B2 (en) 2007-09-07 2014-02-12 キュー エル ティー インク． Detection of lacrimal implant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226562B1 (en) * 1995-02-22 2009-04-28 Novartis Ag 1-aryl-2-acylamino-ethane compounds as neurokinin, especially neurokinin-1 antagonists, and medicaments containing the said compounds.
WO1996041631A1 (en) * 1995-06-09 1996-12-27 Eli Lilly And Company Methods of treating cold and allergic rhinitis
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
IT1304898B1 (en) * 1998-09-08 2001-04-05 Menarini Ricerche Spa PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS

Also Published As

Publication number Publication date
GB0010958D0 (en) 2000-06-28
WO2001085696A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU3021001A (en) Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer
AU2002221881A1 (en) Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
IL150260A0 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity
AU2002223599A1 (en) Pyrimidinone derivatives and their use in the treatment of atherosclerosis
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU4171500A (en) Flupirtine in the treatment of fibromyalgia and related conditions
PL369655A1 (en) Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives, process for its preparation and their use in the preparation of pharmaceutically important compounds
AU2710500A (en) Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU1164601A (en) Therapeutic use and formulation
AU5240700A (en) Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU2001265186A1 (en) Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
SI1197485T1 (en) Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
AU2001254825A1 (en) Butenoic acids derivatives and their use in the treatment of rhinitis
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
IL127464A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas